BridgeBio Pharma (BBIO) Other Non Operating Income (2018 - 2025)
BridgeBio Pharma (BBIO) reported Other Non Operating Income of $21.2 million for Q4 2025, up 157.02% sequentially from $8.2 million in Q1 2025.
BridgeBio Pharma (BBIO) Other Non Operating Income (2018 - 2025) Analysis & Trends
BridgeBio Pharma (BBIO) has 7 years of Other Non Operating Income data on file, last reported at $21.2 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income changed N/A year-over-year to $21.2 million; the trailing twelve-month figure through Mar 2026 stood at $21.2 million (up 157.02% YoY), and the FY2024 full-year result was -$26.6 million, changed N/A from the prior year.
- Other Non Operating Income advanced to $21.2 million in Q4 2025, from $8.2 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $28.3 million in Q4 2021 to a low of -$26.6 million in Q1 2024.
- A 4-year average of $2.8 million and a median of $4.6 million in 2022 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 1116.46% in 2021, while the deepest fall reached 7700.0% in 2021.
- Tracing BBIO's Other Non Operating Income over 4 years: stood at $28.3 million in 2021, then slumped by 83.88% to $4.6 million in 2022, then slumped by 683.11% to -$26.6 million in 2024, then jumped by 179.56% to $21.2 million in 2025.
- Business Quant data shows BBIO's Other Non Operating Income at $21.2 million in Q4 2025, $8.2 million in Q1 2025, and -$26.6 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.16 Mn |
| Mar 31, 2025 | 8.23 Mn |
| Mar 31, 2024 | -26.59 Mn |
| Dec 31, 2022 | 4.56 Mn |
| Sep 30, 2022 | 6.33 Mn |
| Jun 30, 2022 | -10.82 Mn |
| Mar 31, 2022 | -7.58 Mn |
| Dec 31, 2021 | 28.28 Mn |
| Sep 30, 2021 | -684,000.00 |
| Jun 30, 2021 | 2.46 Mn |
| Mar 31, 2021 | 5.77 Mn |
| Dec 31, 2020 | 2.98 Mn |
| Sep 30, 2020 | 9,000.00 |
| Jun 30, 2020 | -1.83 Mn |
| Mar 31, 2020 | 474,000.00 |
| Dec 31, 2019 | -158,000.00 |
| Sep 30, 2019 | -166,000.00 |
| Jun 30, 2019 | 219,000.00 |
| Mar 31, 2019 | -1.52 Mn |
| Dec 31, 2018 | -3.00 Mn |